Characterization of meningococcal disease outbreaks in the United States, 2014–2019
PLOS One · 18.11.2026 · 21 (11) · e0362457
DOI: 10.1371/journal.pone.0362457 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 18.11.2026. Verfasst von Gabrielle A Cooper und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georg…. Hauptthemen laut MEDLINE: Disease Outbreaks, Meningococcal Infections, Neisseria meningitidis. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0).
Abstract (Originalsprache)
Background
Meningococcal disease, caused by the bacterium Neisseria meningitidis , is a serious bacterial infection that can be fatal or leave survivors with permanent sequelae. Despite decades of declining incidence in the United States (U.S.), meningococcal disease outbreaks are still of public health concern.
Methods
Meningococcal disease cases reported through the National Notifiable Diseases Surveillance System along with additional data provided by jurisdiction health departments were used to identify outbreak-associated cases and public health response measures during 2014–2019. Outbreaks were defined as 2–3 cases within an organization during a 3-month period, an incidence of meningococcal disease above expected in a community during a 3-month period, or ≥2 cases that occurred in the same family or household during a 24-month period.
Results
Twenty-nine meningococcal disease outbreaks were reported in the U.S. during 2014 – 2019 (18 organization, 8 community, 3 household). Outbreak-associated cases (n = 130), accounted for 5.8% of all meningococcal disease cases (n = 2,228) reported during 2014 – 2019 and were predominantly serogroups B and C. Community outbreaks had longer median durations (203 days) compared to family/household and organization outbreaks (136 days and 9 days, respectively). Of the 7 family/household outbreak-associated cases, only 2 occurred within 14 days of each other. Based on available information for 23 outbreaks, a response measure was implemented in 21 outbreaks: mass vaccination campaign alone (14), expanded chemoprophylaxis alone (2), and both mass vaccination campaign and expanded chemoprophylaxis (5).
Conclusion
We identified outbreaks of meningococcal disease in a variety of settings and populations; however, this is the first time family/household outbreaks have been systematically characterized in the U.S. Our findings suggest that household contacts of meningococcal disease patients may be at increased disease risk beyond direct secondary transmission. Additional evaluations will be helpful to better assess the potential benefit of vaccination for family members of cases in household settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
- National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, Georgia.
ORCID-Profile: Gabrielle A Cooper, How Yi Chang
Zitieren
APA
Cooper, G. A., Brown, N. E., Rubis, A. B., Chang, H. Y., Cubenas, C., Marasini, D., Retchless, A., Sharma, S., Meyer, S., & McNamara, L. A. (2026). Characterization of meningococcal disease outbreaks in the United States, 2014–2019. PLOS One, 21(11), e0362457. https://doi.org/10.1371/journal.pone.0362457
Vancouver
Cooper GA, Brown NE, Rubis AB, Chang HY, Cubenas C, Marasini D, et al. Characterization of meningococcal disease outbreaks in the United States, 2014–2019. PLOS One. 2026;21(11):e0362457. doi:10.1371/journal.pone.0362457
BibTeX
@article{Cooper2026,
author = {Cooper, Gabrielle A and Brown, Nicole E and Rubis, Amy B and Chang, How Yi and Cubenas, Caelin and Marasini, Daya and Retchless, Adam and Sharma, Shalabh and Meyer, Sarah and McNamara, Lucy A},
title = {Characterization of meningococcal disease outbreaks in the United States, 2014–2019},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {11},
pages = {e0362457},
doi = {10.1371/journal.pone.0362457}
}
EUVIMED